Coronary vasospasm-induced acute diastolic dysfunction in a patient with Raynaud's phenomenon

Clinical Research in Cardiology

Volumn 95, Issue 6, 2006, Pages 344-348

  Tschöpe, Carsten ^a   Westermann, Dirk ^a   Steendijk, Paul ^b   Kasner, Mario ^a   Rudwaleit, Martin ^a   Schwimmbeck, Peter L ^a   Poller, Wolfgang C ^a   Schultheiss, Heinz Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coronary vasospasm; Diastolic dysfunction; Pressure volume loops; Raynaud's phenomenon

Indexed keywords

AMLODIPINE; CICLITANIN; DILTIAZEM; ERGOMETRINE; ILOPROST; ISOSORBIDE DINITRATE; MAGNESIUM; MOLSIDOMINE; PROSTACYCLIN DERIVATIVE; RAMIPRIL; SIMVASTATIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY SPASM; DIASTOLE; DYSPNEA; FEMALE; HEART CATHETERIZATION; HEART DIASTOLE DYSFUNCTION; HEART DISEASE; HEART VENTRICLE CONDUCTION; HUMAN; RAYNAUD PHENOMENON; SYSTOLE;

CORONARY VASOSPASM; DIASTOLE; FEMALE; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; MIDDLE AGED; RAYNAUD DISEASE;

EID: 33744953093     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-0384-9     Document Type: Article

References (10)

1. Kass DA, Midei M, Graves W, Brinker JA, Maughan WL (1988) Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn 15:192-202
2. Mittag M, Beckheinrich P, Haustein UF (2001) Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels. Acta Derm Venereol 81:294-297
3. Scorza R, Caronni M, Mascagni B, Berruti V, Bazzi S, Micallef E, Arpaia G, Sardina M, Origgi L, Vanoli M (2001) Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized, controlled study. Clin Exp Rheumatol 19:503-508
4. Tzivoni D (1993) Effect of transient ischemia on left ventricular function and prognosis. Eur Heart J 14 (Suppl A):2-7
5. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539-548
6. Tschöpe C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kuhl U, Kandolf R, Schultheiss HP (2005) High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111:879-986
7. Maeder M, Ammann P, Angehrn W, Rickli H (2003) A case of coronary vasospasm treated with stent placement. Z Kardiol 92:182-187
8. Generini S, Del Rosso A, Pignone A, Matucci-Cerinic M (2003) Current treatment options in Raynaud's phenomenon. Curr Treat Options Cardiovasc Med 5:147-161
9. Miller D, Waters DD, Warnica W, Szlachcic J, Kreeft J, Theroux P (1981) Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med 304:763-766
10. Boin F, Wigley FM (2005) Understanding, assessing and treating Raynaud's phenomenon. Curr Opin Rheumatol 17:752-760